Sarepta Therapeutics (NASDAQ:SRPT) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Sarepta Therapeutics beat estimated earnings by 55.91%, reporting an EPS of $-0.56 versus an estimate of $-1.27.
Revenue was up $63.90 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.36 which was followed by a 4.66% increase in the share price the next day.
Here's a look at Sarepta Therapeutics's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -1.13 | -1.89 | -1.29 | -1.78 |
| EPS Actual | -0.77 | -0.19 | -1.52 | -1.54 |
| Revenue Estimate | 198.61M | 173.42M | 162.64M | 143.33M |
| Revenue Actual | 201.46M | 189.41M | 164.09M | 146.93M |
To track all earnings releases for Sarepta Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
